SCHEMBL22115109

SCHEMBL22115109

C=CC(=O)Nc1cc(N2CCN(CC)CC2)ccc1Nc1ncc2ccc(C(=O)c3c(F)c(OC)cc(OC)c3F)c(NC3CC3)c2n1

nearest known ligand 0.54

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ FGFR1 P11362 6/20 0.54
▸ FGFR4 P22455 5/20 0.54
▸ EGFR P00533 9/20 0.53
▸ FGFR2 P21802 2/20 0.48
▸ FGFR3 P22607 1/20 0.48
▸ MAPK3 P27361 4/20 0.47
▸ KDR P35968 1/20 0.44
▸ GAK O14976 1/20 0.44
▸ FES P07332 1/20 0.44
▸ FER P16591 1/20 0.44
▸ ERBB3 P21860 1/20 0.44
▸ TEC P42680 1/20 0.44
▸ CLK1 P49759 1/20 0.44
▸ JAK3 P52333 1/20 0.44
▸ PTK2 Q05397 1/20 0.44
▸ BTK Q06187 1/20 0.44
▸ TNK1 Q13470 1/20 0.44
▸ ALK Q9UM73 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22115113 0.91 EGFR (0.52) FGFR1FGFR4EGFRFGFR2FGFR3
SCHEMBL22115108 0.89 FGFR4 (0.58) FGFR1FGFR4EGFRFGFR2FGFR3
SCHEMBL22343344 0.84 FGFR4 (0.56) FGFR1FGFR4EGFRFGFR2FGFR3
SCHEMBL22114567 0.84 FGFR4 (0.58) FGFR1FGFR4EGFRFGFR2FGFR3
SCHEMBL22343228 0.83 FGFR4 (0.56) FGFR1FGFR4EGFRFGFR2FGFR3
SCHEMBL22114936 0.82 FGFR4 (0.57) FGFR1FGFR4EGFRFGFR2FGFR3
SCHEMBL22343074 0.82 FGFR4 (0.55) FGFR1FGFR4EGFRFGFR2FGFR3
SCHEMBL22343071 0.82 EGFR (0.56) FGFR1FGFR4EGFRFGFR2FGFR3
SCHEMBL22114817 0.81 FGFR4 (0.52) FGFR1FGFR4EGFRFGFR2FGFR3
SCHEMBL22343195 0.80 FGFR4 (0.55) FGFR1FGFR4EGFRFGFR2FGFR3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2020119606-A1 HETEROCYCLIC COMPOUNDS AS INHIBITORS OF FIBROBLAST GROWTH FACTOR RECEPTOR GUANGDONG NEWOPP BIOPHARMACEUTICALS CO., LTD. (CN) 2020-06-18 — — WO disclosed
Send feedback